Icon

VYTORIN (nda021687)- (10MG;10MG,10MG;20MG,10MG;40MG,10MG;80MG)

EZETIMIBE; SIMVASTATIN ORGANON
10MG;10MG,10MG;20MG,10MG;40MG,10MG;80MG
Yes No
2024-Jun-11 Expired
None None
None No
VYTORIN, which contains a cholesterol absorption inhibitor and an HMG-CoA reductase inhibitor (statin), is indicated as adjunctive therapy to diet to: • reduce elevated total-C, LDL-C, Apo B, TG, and non-HDL-C, and to increase HDL-C in patients with primary (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia. • reduce elevated total-C and LDL-C in patients with homozygous familial hypercholesterolemia (HoFH), as an adjunct to other lipid-lowering treatments.
6 0 6
Total Other Developers 2
Drugs with Suitability No
10MG;10MG ** ** - - 5
10MG;20MG ** ** - - 5
10MG;40MG ** ** Up - 5
10MG;80MG ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***
****** ****** **** *** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ****** ****** ** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ****** ****** ** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** ****** ** ****, ****, ****, **** ******* *****, ****** ********, *****, ******** ******* ******, ***** (***) ***
****** ********* ****** *** ****** ******* *** *********** ******* ******** ****, **** **. *, *, * & *, ***** **, ***********-****** **** ****, *********** ****, *********, ********* ******, ***** (***) ***
****** ********* ****** *** **** *** ***** ******* ***. *** *********** **** **. *-*, *-*/*, *-*/* ****** ********** ****, ****** ****, ********, ****** (***** ****** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.